A multidisciplinary nephrogenetic referral clinic for children and adults-diagnostic achievements and insights.

Inherited kidney diseases Nephrogenetics Next generation sequencing Renal genetics Whole exome sequencing

Journal

Pediatric nephrology (Berlin, Germany)
ISSN: 1432-198X
Titre abrégé: Pediatr Nephrol
Pays: Germany
ID NLM: 8708728

Informations de publication

Date de publication:
07 2022
Historique:
received: 23 08 2021
accepted: 17 11 2021
revised: 16 11 2021
pubmed: 8 1 2022
medline: 16 6 2022
entrez: 7 1 2022
Statut: ppublish

Résumé

Genetic kidney diseases contribute a significant portion of kidney diseases in children and young adults. Nephrogenetics is a rapidly evolving subspecialty; however, in the clinical setting, increased use of genetic testing poses implementation challenges. Consequently, we established a national nephrogenetics clinic to apply a multidisciplinary model. Patients were referred from different pediatric or adult nephrology units across the country if their primary nephrologist suspected an undiagnosed genetic kidney disease. We determined the diagnostic rate and observed the effect of diagnosis on medical care. We also discuss the requirements of a nephrogenetics clinic in terms of logistics, recommended indications for referral, and building a multidisciplinary team. Over 24 months, genetic evaluation was completed for a total of 74 unrelated probands, with an age range of 10 days to 72 years. The most common phenotypes included congenital anomalies of the kidneys and urinary tract, nephrotic syndrome or unexplained proteinuria, nephrocalcinosis/nephrolithiasis, tubulopathies, and unexplained kidney failure. Over 80% of patients were referred due to clinical suspicion of an undetermined underlying genetic diagnosis. A molecular diagnosis was reached in 42/74 probands, yielding a diagnostic rate of 57%. Of these, over 71% of diagnoses were made via next generation sequencing (gene panel or exome sequencing). We identified a substantial fraction of genetic kidney etiologies among previously undiagnosed individuals which influenced subsequent clinical management. Our results support that nephrogenetics, a rapidly evolving field, may benefit from well-defined multidisciplinary co-management administered by a designated team of nephrologist, geneticist, and bioinformatician. A higher resolution version of the Graphical abstract is available as Supplementary information.

Sections du résumé

BACKGROUND
Genetic kidney diseases contribute a significant portion of kidney diseases in children and young adults. Nephrogenetics is a rapidly evolving subspecialty; however, in the clinical setting, increased use of genetic testing poses implementation challenges. Consequently, we established a national nephrogenetics clinic to apply a multidisciplinary model.
METHODS
Patients were referred from different pediatric or adult nephrology units across the country if their primary nephrologist suspected an undiagnosed genetic kidney disease. We determined the diagnostic rate and observed the effect of diagnosis on medical care. We also discuss the requirements of a nephrogenetics clinic in terms of logistics, recommended indications for referral, and building a multidisciplinary team.
RESULTS
Over 24 months, genetic evaluation was completed for a total of 74 unrelated probands, with an age range of 10 days to 72 years. The most common phenotypes included congenital anomalies of the kidneys and urinary tract, nephrotic syndrome or unexplained proteinuria, nephrocalcinosis/nephrolithiasis, tubulopathies, and unexplained kidney failure. Over 80% of patients were referred due to clinical suspicion of an undetermined underlying genetic diagnosis. A molecular diagnosis was reached in 42/74 probands, yielding a diagnostic rate of 57%. Of these, over 71% of diagnoses were made via next generation sequencing (gene panel or exome sequencing).
CONCLUSIONS
We identified a substantial fraction of genetic kidney etiologies among previously undiagnosed individuals which influenced subsequent clinical management. Our results support that nephrogenetics, a rapidly evolving field, may benefit from well-defined multidisciplinary co-management administered by a designated team of nephrologist, geneticist, and bioinformatician. A higher resolution version of the Graphical abstract is available as Supplementary information.

Identifiants

pubmed: 34993602
doi: 10.1007/s00467-021-05374-4
pii: 10.1007/s00467-021-05374-4
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1623-1646

Informations de copyright

© 2021. The Author(s), under exclusive licence to International Pediatric Nephrology Association.

Références

Connaughton DM, Hildebrandt F (2020) Personalized medicine in chronic kidney disease by detection of monogenic mutations. Nephrol Dial Transplant 35:390–397
doi: 10.1093/ndt/gfz028
Groopman EE, Marasa M, Cameron-Christie S, Petrovski S et al (2019) Diagnostic utility of exome sequencing for kidney diseases. N Engl J Med 380:142–151
doi: 10.1056/NEJMoa1806891
Connaughton DM, Kennedy C, Shril S, Mann N et al (2019) Monogenic causes of chronic kidney disease in adults. Kidney Int 95:914–928
doi: 10.1016/j.kint.2018.10.031
Vaisitti T, Sorbini M, Callegari M, Kalantari S et al (2021) Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience. J Nephrol 34:1767–1781
doi: 10.1007/s40620-020-00898-8
Schrezenmeier E, Kremerskothen E, Halleck F, Staeck O et al (2021) The underestimated burden of monogenic kidney disease in adults waitlisted for kidney transplantation. Genet Med 23:1219–1224
doi: 10.1038/s41436-021-01127-8
Hays T, Groopman EE, Gharavi AG (2020) Genetics testing for kidney disease of unknown etiology. Kidney Int 8:590–600
doi: 10.1016/j.kint.2020.03.031
Groopman EE, Rasouly HM, Gharavi AG (2018) Genomic medicine for kidney disease. Nat Rev Nephrol 14:83–104
doi: 10.1038/nrneph.2017.167
Vivante A, Hildebrandt F (2016) Exploring the genetic basis of early-onset chronic kidney disease. Nat Rev Nephrol 12:133–146
doi: 10.1038/nrneph.2015.205
Vivante A, Hwang DY, Kohl S, Chen J et al (2017) Exome sequencing discerns syndromes in patients from consanguineous families with congenital anomalies of the kidneys and urinary tract. J Am Soc Nephrol 28:69–75
doi: 10.1681/ASN.2015080962
Holmberg C, Jalanko H (2014) Congenital nephrotic syndrome and recurrence of proteinuria after renal transplantation. Pediatr Nephrol 29:2309–2317
doi: 10.1007/s00467-014-2781-z
Mallett A, Corney C, McCarthy H, Alexander SI, Healy H (2015) Genomics in the renal clinic – translating nephrogenetics for clinical practice. Hum Genomics 9:13
doi: 10.1186/s40246-015-0035-1
Tirosh I, Spielman S, Barel O, Ram R et al (2019) Whole exome sequencing in childhood-onset lupus frequently detects single gene etiologies. Pediatr Rheumatol Online J 17:52
doi: 10.1186/s12969-019-0349-y
Gillis D, Krishnamohan A, Yaacov B, Shaag A, Jackman JE, Elpeleg O (2014) TRMT10A dysfunction is associated with abnormalities in glucose homeostasis, short stature and microcephaly. J Med Genet 51:581–586
doi: 10.1136/jmedgenet-2014-102282
Kohl S, Hwang DY, Dworschak GC, Hilger AC et al (2014) Mild recessive mutations in six Fraser syndrome-related genes cause isolated congenital anomalies of the kidney and urinary tract. J Am Soc Nephrol 25:1917–1922
doi: 10.1681/ASN.2013101103
Gale DP, Mallett A, Patel C, Sneddon TP et al (2020) Diagnoses of uncertain significance: kidney genetics in the 21st century. Nat Rev Nephrol 16:616–618
doi: 10.1038/s41581-020-0277-6
Miller DT, Lee K, Gordon AS, Amendola LM et al (2021) Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 23:1391–1398
doi: 10.1038/s41436-021-01171-4
Vivante A, Mark-Danieli M, Davidovits M, Harari-Steinberg O et al (2013) Renal hypodysplasia associates with a WNT4 variant that causes aberrant canonical WNT signaling. J Am Soc Nephrol 24:550–558
doi: 10.1681/ASN.2012010097
Thomas CP, Freese ME, Ounda A, Jetton JG, Holida M, Noureddine L, Smith RJ (2020) Initial experience from a renal genetics clinic demonstrates a distinct role in patient management. Genet Med 22:1025–1035
doi: 10.1038/s41436-020-0772-y
Jayasinghe K, Stark Z, Kerr PG, Gaff C et al (2021) Clinical impact of genomic testing in patients with suspected monogenic kidney disease. Genet Med 3:183–191
doi: 10.1038/s41436-020-00963-4
Mansilla MA, Sompallae RR, Nishimura CJ, Kwitek AE et al (2021) Targeted broad-based genetic testing by next-generation sequencing informs diagnosis and facilitates management in patients with kidney diseases. Nephrol Dial Transplant 36:295–305
doi: 10.1093/ndt/gfz173
Gulati A, Somlo S (2018) Whole exome sequencing: a state-of-the-art approach for defining (and exploring!) genetic landscapes in pediatric nephrology. Pediatr Nephrol 33:745–761
doi: 10.1007/s00467-017-3698-0
Gambaro G, Fabris A, Citron L, Tosetto E et al (2005) An unusual association of contralateral congenital small kidney, reduced renal function and hyperparathyroidism in sponge kidney patients: on the track of the molecular basis. Nephrol Dial Transplant 20:1042–1047
doi: 10.1093/ndt/gfh798
Torregrossa R, Anglani F, Fabris A, Gozzini A et al (2010) Identification of GDNF gene sequence variations in patients with medullary sponge kidney disease. Clin J Am Soc Nephrol 5:1205–1210
doi: 10.2215/CJN.07551009
Eichinger J, Elger BS, Koné I, Filges I et al (2021) The full spectrum of ethical issues in pediatric genome-wide sequencing: a systematic qualitative review. BMC Pediatr 21:387
doi: 10.1186/s12887-021-02830-w
Verbitsky M, Westland R, Perez A, Kiryluk K et al (2019) The copy number variation landscape of congenital anomalies of the kidney and urinary tract. Nat Genet 51:117–127
doi: 10.1038/s41588-018-0281-y
Bierzynska A, Saleem MA (2020) Genetic architecture of paediatric renal diseases in China and the need for data sharing. Transl Pediatr 9:202–205
doi: 10.21037/tp-20-135
Rao J, Liu X, Mao J, Tang X et al (2019) Genetic spectrum of renal disease for 1001 Chinese children based on a multicenter registration system. Clin Genet 96:402–410
doi: 10.1111/cge.13606
Mann N, Braun DA, Amann K, Tan W et al (2019) Whole-exome sequencing enables a precision medicine approach for kidney transplant recipients. J Am Soc Nephrol 30:201–215
doi: 10.1681/ASN.2018060575
Snoek R, van Jaarsveld RH, Nguyen TQ, Peters EDJ et al (2020) Genetics-first approach improves diagnostics of ESKD patients younger than 50 years. Nephrol Dial Transplant. https://doi.org/10.1093/ndt/gfaa363
doi: 10.1093/ndt/gfaa363

Auteurs

Ben Pode-Shakked (B)

Department of Pediatrics B, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, 5265601, Ramat Gan, Israel.
The Institute for Rare Diseases, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.
The Talpiot Medical Leadership Program, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Yishay Ben-Moshe (Y)

Department of Pediatrics B, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, 5265601, Ramat Gan, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Ortal Barel (O)

The Genomic Unit, Sheba Cancer Research Center, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.
The Wohl Institute for Translational Medicine, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Lilach C Regev (LC)

Department of Pediatrics B, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, 5265601, Ramat Gan, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Maayan Kagan (M)

Department of Pediatrics B, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, 5265601, Ramat Gan, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Aviva Eliyahu (A)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
The Danek Gertner Institute for Human Genetics, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Dina Marek-Yagel (D)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
The Wohl Institute for Translational Medicine, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.
Metabolic Disease Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Danit Atias-Varon (D)

Pediatric Nephrology Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Einat Lahav (E)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Pediatric Nephrology Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Naomi Issler (N)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Pediatric Nephrology Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Omer Shlomovitz (O)

Department of Pediatrics B, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, 5265601, Ramat Gan, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Rotem Semo Oz (R)

Department of Pediatrics B, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, 5265601, Ramat Gan, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Nitzan Kol (N)

The Genomic Unit, Sheba Cancer Research Center, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Nofar Mor (N)

The Genomic Unit, Sheba Cancer Research Center, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Ifat Bar-Joseph (I)

The Genomic Unit, Sheba Cancer Research Center, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Yulia Khavkin (Y)

The Genomic Unit, Sheba Cancer Research Center, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Elisheva Javasky (E)

The Genomic Unit, Sheba Cancer Research Center, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Pazit Beckerman (P)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Institute of Nephrology and Hypertension, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Meidad Greenberg (M)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Pediatric Nephrology Unit, Meir Medical Center, Kfar Saba, Israel.

Oded Volovelsky (O)

Pediatric Nephrology Unit and Research Lab, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Wohl Translational Research Institute, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Yael Borovitz (Y)

Institute of Nephrology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.

Miriam Davidovits (M)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Institute of Nephrology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.

Orly Haskin (O)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Institute of Nephrology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.

Hadas Alfandary (H)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Institute of Nephrology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.

Shely Levi (S)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Institute of Nephrology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.

Maital Kaidar (M)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Pediatric Nephrology Unit, Edith Wolfson Medical Center, Holon, Israel.

Ze'ev Katzir (Z)

Nephrology and Hypertension Institute, Samson Assuta University Hospital, Ashdod, Israel.
Ben Gurion University, Beer Sheva, Israel.

Avital Angel-Korman (A)

Nephrology and Hypertension Institute, Samson Assuta University Hospital, Ashdod, Israel.
Ben Gurion University, Beer Sheva, Israel.

Rachel Becker-Cohen (R)

Institute of Pediatric Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel.
Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Efrat Ben-Shalom (E)

Institute of Pediatric Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel.
Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Adi Leiba (A)

Nephrology and Hypertension Institute, Samson Assuta University Hospital, Ashdod, Israel.
Ben Gurion University, Beer Sheva, Israel.
Israel Defense Forces Medical Corps, Tel Aviv, Israel.
Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Boston, MA, USA.

Eytan Mor (E)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Transplant Center, Department of Surgery and Transplantation, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Amit Dagan (A)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Institute of Nephrology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.

Itai M Pessach (IM)

The Talpiot Medical Leadership Program, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Department of Pediatric Intensive Care, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Danny Lotan (D)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Pediatric Nephrology Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Moshe Shashar (M)

Nephrology Section, Laniado Hospital, Netanya, Israel.
The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.

Yair Anikster (Y)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
The Wohl Institute for Translational Medicine, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.
Metabolic Disease Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Annick Raas-Rothschild (A)

The Institute for Rare Diseases, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Gideon Rechavi (G)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
The Genomic Unit, Sheba Cancer Research Center, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.
The Wohl Institute for Translational Medicine, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Benjamin Dekel (B)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Pediatric Nephrology Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.
Pediatric Stem Cell Research Institute, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Asaf Vivante (A)

Department of Pediatrics B, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, 5265601, Ramat Gan, Israel. asafvivante@gmail.com.
The Talpiot Medical Leadership Program, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel. asafvivante@gmail.com.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. asafvivante@gmail.com.
Pediatric Nephrology Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel. asafvivante@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH